Results 101 to 110 of about 150,246 (305)

Preoperative Gemcitabine/Nab‐Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Although NCCN guidelines recommend preoperative therapy for borderline resectable pancreatic cancer (BR‐PC), it is still unclear which regimen is better. The study objective was to elucidate the prognostic significance of neoadjuvant chemoradiotherapy (NACRT) with gemcitabine/nab‐paclitaxel (GnP‐RT) compared to gemcitabine alone ...
Hirofumi Akita, Hidenori Takahashi, Yousuke Mukai, Masahiko Kubo, Shinichiro Hasegawa, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Hiroshi Wada, Kunihito Gotoh   +9 more
wiley   +1 more source

Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion following Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: An Initial Experience [PDF]

Objective: To investigate the outcomes of robot-assisted radical cystectomy, intracorporeal urinary diversion, and extended lymph node dissection in patients with muscle-invasive bladder cancer who underwent neoadjuvant chemotherapy.
Tünkut Doğanca, Ömer Burak Argun, İlter Tüfek, Can Öbek, Ali Rıza Kural, Mustafa Bilal Tuna   +5 more
core   +1 more source

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

Annals of Gastroenterological Surgery, EarlyView.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya, Koichi Yagi, Yoshifumi Baba   +2 more
wiley   +1 more source

Long–term survival of patients after multimodal treatment of stage IIIA(N2) non–small cell lung cancer

Український журнал клінічної хірургії
Objective. To determine the overall and recurrence–free survival rates of patients with stage IIIA(N2) non–small cell lung cancer after various multimodal treatment regimens. Materials and methods. A comparative study of different modes of neoadjuvant
V. D. Zakharychev, P. I. Hordiychuk, B. O. Borysiuk   +2 more
doaj   +1 more source

Identification of residual breast carcinoma following neoadjuvant chemotherapy: Diffusion-weighted imaging - comparison with contrast-enhanced MR imaging and pathologic findings

, 2010
Purpose.\ud \ud To compare the capability of diffusion-weighted (DW) and contrast material–enhanced magnetic resonance (MR) imaging to provide diagnostic information on residual breast cancers following neoadjuvant chemotherapy and to assess apparent ...
Hatabu, Hiroto, Hata, Hirofumi, Mountford, Carolyn E., Gautam, Shiva, Mountford, Carolyn, Kan, Shinichi, Iwabuchi, Keiichi, Kuranami, Masaru, Woodhams, Reiko, Kakita, Satoko   +9 more
core   +1 more source

Effect of Broad‐Spectrum Antibiotic Prophylaxis on Post‐Pancreatoduodenectomy Infectious Complications: Nationwide Inpatient Database Study in Japan

Annals of Gastroenterological Surgery, EarlyView.
Using a nationwide Japanese inpatient database, we evaluated whether broad‐spectrum antibiotic prophylaxis improves postoperative outcomes after pancreatoduodenectomy compared with narrow‐spectrum antibiotics. In propensity score–weighted analyses of 45 099 patients, broad‐spectrum prophylaxis was associated with significantly lower rates of intra ...
Hiroki Kitagawa, Shotaro Aso, Yuki Hirano, Kenichiro Uemura, Keita Kouzu, Satoru Matsuda, Hiroki Matsui, Kiyohide Fushimi, Junichi Sasaki, Yuko Kitagawa, Hideo Yasunaga   +10 more
wiley   +1 more source

Neo-adjuvant chemotherapy in osteosarcoma. Results of a multicentric study in Italy

, 1988
Neoadjuvant chemotherapy in osteosarcoma.
CAPANNA, RODOLFO, BRACH DEL PREVER A, P. RUGGIERI, BALDINI N, MANCINI A. M, BIAGINI R, M. AVELLA, N. BALDINI, A. M. MANCINI, E. FIGUS, A. BRACH DEL PREVER, M. FIORENTINI, PICCI P, FIORENTINI M, G. BACCI, BACCI G, CAPANNA R, RUGGIERI, PIETRO, R. BIAGINI, AVELLA M, M. MERCURI, P. PICCI, M. CAMPANACCI, FIGUS E, CAMPANACCI M, MERCURI M   +25 more
core  

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma

, 2012
Back ground: nasopharyngeal carcinoma is rare in Iraq and the treatment of this tumor is usually by radiotherapy and chemotherapy. Objectives: this study was conducted to estimate the effect of neoadjuvant chemotherapy in Iraqi patients with ...
Khudair J. Sabeeh Al-Rawaq
core   +1 more source

Management Strategies for Disappearing Colorectal Liver Metastases After Systemic Chemotherapy: Long‐Term Outcomes and Preoperative Prediction of ‘True Complete Response’

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Determining whether to resect disappearing liver metastases (DLMs) after chemotherapy for colorectal liver metastases (CRLMs) remains challenging. Methods Patients who underwent hepatectomy after systemic chemotherapy for initially unresectable CRLMs were reviewed. True complete response (CR) was defined as either resected DLMs with
Taihei Soma, Ryo Ashida, Takeshi Kawakami, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Yoshiyasu Kato, Kentaro Yamazaki, Katsuhiko Uesaka, Teiichi Sugiura   +9 more
wiley   +1 more source

Analysis of the effects of different treatment methods in patients with stage Ⅰb2 bullky cervical cancer

Zhongguo aizheng zazhi, 2015
Background and purpose: A variety of measures are taken preoperatively to reduce the tumor size of stage Ⅰb2 bulky cervical cancer before surgery. Which one is safer and more effective, currently, there is no consensus.
韩娜娜, 邵文裕
doaj